Susan Morrison - Tandem Diabetes Insider

Tandem Diabetes Care Inc -- USA Stock  

USD 2.55  0.07  2.82%

Chief Admin. Officer

Susan M. Morrison is Chief Administrative Officer at Tandem Diabetes Care, Inc. since September 2013. From April 2013 until September 2013, she served as our Vice President, Human Resources, Corporationrationrate and Investor Relations. Ms. Morrison served as our Director, Corporationrationrate and Investor Relations, from January 2009 to March 2013, and was our Director, Corporationrationrate Services from November 2007 to December 2008. Prior to joining us, Ms. Morrison held various positions in Corporationrationrate and Investor Relations at Biosite from August 2003 through November 2007
Age: 34  Executive Since 2013      
858-366-6900  www.tandemdiabetes.com
Morrison holds a B.A. in Public Relations from Western Michigan University.

Management Efficiency

The company has return on total asset (ROA) of (49.31) % which means that it has lost $49.31 on every $100 spent on asset. This is way below average.
The company currently holds 74.68 M in liabilities with Debt to Equity (D/E) ratio of 8.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Tandem Diabetes Care Inc has Current Ratio of 2.07 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various solutions for people with insulindependent diabetes in the United States. Tandem Diabetes Care Inc (TNDM) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 482 people. Tandem Diabetes is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Balance Of Power Now
   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Hide  View All  Next  Launch Balance Of Power
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Tandem Diabetes Care Inc to your portfolio

Top Management

Tandem Diabetes Care Leadership Team
Brian Hansen, President, MBA
Fred Cohen, Director
Susan Morrison, Executive
Lori Gildea, President, MBA
Howard Greene, Director, MBA
Christopher Twomey, Director
Henry Anhalt, Director
Edward Cahill, Director
Lonnie Smith, Chairman, MBA
John Cajigas, CFO
Dick Allen, Chairman, MBA
David Berger, Executive
Jesse Treu, Director, Ph.D
Douglas Roeder, Director
John Sheridan, COO, MBA
Kim Blickenstaff, CEO, MBA
Robert Anacone, EVP

Stock Performance

Tandem Diabetes Performance Indicators